Patent ID: 7049063

Claim:
A method for determining the presence of a lung squamous carcinoma in a human patient, comprising the steps of: (a) obtaining a lung tissue sample from the patient; (b) contacting the lung tissue sample with polynucleotide, wherein said polynucleotide comprises the cDNA set forth in SEQ ID NO:160, or the complement thereof; (c) detecting an amount of said polynucleotide that specifically hybridizes to the cDNA set forth in SEQ ID NO:160 in the lung tissue sample; and (d) comparing the amount of the polynucleotide that specifically hybridizes to the cDNA set forth in SEQ ID NO:160 in the lung tissue sample to the amount of the polynucleotide that specifically hybridizes to the cDNA set forth in SEQ ID NO:160 in a non-cancerous lung tissue sample; wherein at least a two-fold increase in the amount of the polynucleotide that specifically hybridizes to the cDNA set forth in SEQ ID NO:160 in the lung tissue sample as compared to the amount of the polynucleotide that specifically hybridizes to the cDNA set forth in SEQ ID NO:160 in the non-cancerous lung tissue sample indicates the presence of squamous carcinoma in the patient.